SynthesisBlood cancer journal2026

Pola-R-CHP as frontline therapy for diffuse large B-cell lymphoma: a systematic review and meta-analysis of randomized trials and real-world evidence.

Salvatore Perrone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.